When was Gleamer founded?

Gleamer was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Gleamer located?

Gleamer is headquartered in Paris, France.

Who is the current CEO of Gleamer?

Christian Allouche of Gleamer. They have also founded 1 company.

How many employees does Gleamer have?

As of Oct 31, 2026, the latest employee count at Gleamer is 116.

Is Gleamer a funded company?

Gleamer is a funded company, having raised a total of $40M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 24, 2018.

When was the latest funding round of Gleamer?

Gleamer's latest funding was a $***** Series B round on Jun 28, 2023, with participation from 9 investors.

Where does Gleamer rank among its competitors?

Gleamer ranks 6th amongst 760 active competitors, of which 173 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was CARPL, which secured $10M in Jul, 2026.

Who are the top competitors of Gleamer?

Gleamer's top competitors include Qure.ai, Perspectum and AIdoc. Among them, CARPL secured the most recent funding round in July, 2026.

Gleamer - 2026 Company Profile, Team, Funding & Competitors

Gleamer is an acquired company based in Paris (France), founded in 2017 by Nicolas COSME, Alexis Ducarouge, Nor-eddine Regnard and Christian Allouche. It operates as a Developer of artificial intelligence software for medical imaging diagnostic analysis. Gleamer has raised $40M in funding from investors like Elaia, XAnge and MACSF. The company has 760 active competitors, including 173 funded and 44 that have exited. Its top competitors include companies like Qure.ai, Perspectum and AIdoc.

Company Details

Developer of artificial intelligence software for medical imaging diagnostic analysis. This technology integrates with existing radiology workflows to assist in the detection and assessment of pathologies across various modalities including X-ray, computed tomography, and magnetic resonance imaging. The software provides automated measurements, worklist prioritization, and reporting assistance to support clinical image interpretation. These tools function as a gateway for deploying diagnostic algorithms that process medical data to identify abnormalities in bone, chest, breast, and neurological scans.

Key Metrics

Founded Year

2017

Location

Paris, France

Stage

Acquired

Total Funding

$40M in 4 rounds

Latest Funding Round

Series B, Jun 28, 2023, $*****

Investors

Elaia & 12 more

Ranked

6^th among 760 active competitors

Employee Count

116 as on Oct 31, 2026

Investment & Acquisitions

Pixyl

Similar Companies

OpenEvidence & 3117 more

Exit Details

Acquired by RadNet (Mar 02, 2026)

View Gleamer's full profile

Gleamer is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
GLEAMER INC CIN: 88-1371824 , United States, Active		-	-	-
GLEAMER CIN: 834105470 , France, Active	Nov 12, 2017	-	4 (As on Dec 31, 2023)	-

Gleamer got acquired by RadNet on Mar 02, 2026.

Click here to take a look at Gleamer's acquisition in detail

Gleamer has raised a total funding of $40M over 4 rounds. Its first funding round was on Sep 24, 2018. Its latest funding round was a Series B round on Jun 28, 2023 for $*****. 9 investors participated in its latest round. Gleamer has 13 institutional investors.

Here is the list of recent funding rounds of Gleamer:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 28, 2023	5290250	Series B	9977739	9217645	2909505	9439434
Sep 24, 2020	9187280	Series A	5598382	8032819	2600333	5520497
Jul 10, 2019	5004089	Grant (prize money)	5672532	2334980	9391782	EIT Health

Access funding benchmarks and valuations. Sign up today!

View details of Gleamer's funding rounds and investors

The founders of Gleamer are Nicolas COSME, Alexis Ducarouge, Nor-eddine Regnard and Christian Allouche. Christian Allouche is the CEO of Gleamer.

Here are the details of Gleamer's key team members:

Nicolas COSME: Former Co-Founder of Gleamer.
Alexis Ducarouge: Co-Founder & Chief Innovation Officer of Gleamer.
Nor-eddine Regnard: Co-Founder & Chief Medical Officer of Gleamer.
Christian Allouche: Co-Founder & CEO of Gleamer.
Contact Info: 1 email address

View details of Gleamer's Founder profiles and Board Members

Gleamer's employee count trend

Gleamer has 116 employees as of Oct 26. Here is Gleamer's employee count trend over the years:

Uncover Gleamer's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Gleamer include Qure.ai, Perspectum and AIdoc. Here is the list of Top 10 competitors of Gleamer, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Qure.ai 2016, Mumbai (India), Series D	Developer of artificial intelligence software for medical imaging diagnostic analysis	$123M	HealthQuad, 360 One & 49 others	74/100
2nd	Perspectum 2012, Oxford (United Kingdom), Series C	Developer of medical imaging software for analyzing liver disease biomarkers	$140M	Oppenheimer, Health Quest Capital & 32 others	73/100
3rd	AIdoc 2016, New York City (United States), Series E	Developer of clinical AI solutions for healthcare imaging and patient management	$534M	AIC, General Catalyst & 35 others	69/100
4th	Oxipit 2017, Vilnius (Lithuania), Acquired	Developer of medical imaging software for automated radiology diagnostic support	$6.69M	Practica Capital, CoInvest Capital & 4 others	66/100
5th	Subtle Medical 2017, Palo Alto (United States), Series C	AI-driven solutions for medical diagnostic imaging	$86M	Morgan Stanley, 3E Bioventures Capital & 27 others	66/100
6th	Gleamer 2017, Paris (France), Acquired	Developer of artificial intelligence software for medical imaging diagnostic analysis	$40M	Kima Ventures, Crista Galli Ventures & 11 others	66/100
7th	ScreenPoint 2014, Nijmegen (Netherlands), Series C	Developer of artificial intelligence software for analyzing breast imaging mammograms	$47M	Siemens, Insight Partners & 3 others	64/100
8th	Brainomix 2010, Oxford (United Kingdom), Series C	Developer of automated medical imaging software for stroke and lung	$63.3M	Parkwalk, IP Group Hostplus Innovation Fund ... & 17 others	64/100
9th	Cleerly 2016, Denver (United States), Series C	Provider of an AI-driven platform for coronary artery disease assessment	$578M	T. Rowe Price, Fidelity Investments & 20 others	63/100
10th	CARPL 2018, Cupertino (United States), Series A	Provider of an enterprise imaging platform that streamlines radiology workflows through a unified marketplace of artificial intelligence applications	$16M	IFC, Stellaris Venture Partners & 2 others	63/100